GILD
Gilead Sciences, Inc.
Healthcare · in the S&P 500 and the Nasdaq-100
📍 Foster City, United States · See it on the company map
The shape of the figures
Each spoke is one ratio. Further out means a higher figure than more of the index — not a better one. A high P/E or high debt sits far out too, so the size of the shape is not a score.
Drag to turn the shape. Tap or point at a dot to read the figure behind it.
The figures and what each one means are below. A hollow dot means the company doesn't report that figure.
10 years from the annual reports
Source: SEC filings (10-K) ↗Revenue and profit
Revenue was $29.4bn in FY2025, against $30.4bn in FY2016. Net profit was $8.5bn — 29 of every 100 of revenue.
Cash the business generated
In FY2025, operations brought in $10bn; after $563m spent on property and equipment, $9.5bn was left (free cash flow).
Debt and cash at year end
At the end of FY2025 the company reported $24.9bn of long-term debt and $7.6bn of cash and equivalents.
As reported in each year's 10-K, in US dollars. Companies label some items differently, and a year can be missing where a figure wasn't reported in a comparable way.
Key figures, against the S&P 500
Figures as of 9 Nov 2026, refreshed weekly
Each bar places this company among the S&P 500 companies that report that figure. Further right means a higher figure — not a better one. Whether higher or lower suits you depends on what you are looking for, so the bars don't add up to a score.
Valuation
P/E ratio?
16.6x
The share price is 16.6 times the last twelve months' earnings per share.
P/E on average earnings?
43.4x
The share price is 43.4 times earnings per share averaged over recent years.
Price / book
16.0x
The market values the company at 16 times the accounting value of its equity.
EV / EBIT?
20.8x
The company's value including its debt is 20.8 times its operating profit.
Free cash flow yield?
5.1%
Free cash flow equals 5.1% of the company's market value.
Profitability
Return on equity?
-22.5%
Each 100 of shareholders' money produced a loss of 22.5 of net profit.
Return on assets?
13.5%
Each 100 of assets produced 13.5 of net profit.
Return on invested capital
19.7%
Each 100 invested by lenders and owners produced 19.7 of profit.
Operating margin?
36.8%
Of every 100 in sales, 36.8 was left as operating profit.
Debt
Debt / equity?
202.5%
Total debt equals 203% of shareholders' equity.
Net debt / EBITDA?
1.3x
Net debt equals 1.3 years of operating earnings (EBITDA).
Interest cover
10.6x
Operating profit was 10.6 times the interest bill.
Growth
Revenue growth
6.2%
Latest revenue is 6.2% above the average of earlier reported years.
Earnings growth
137.8%
Latest net profit is 137.8% above the average of earlier reported years.
⚠️ Not financial advice
This is a personal project, not professional investment research. The underlying market data may be delayed or incorrect. Nothing here is a recommendation to buy or sell any security. Always do your own research and consult a qualified professional before investing.
This tool is for informational and planning purposes only. It does not constitute financial, investment, tax or legal advice. Always consult a qualified professional before making financial decisions.